Organon & Co. (OGN) revenue and earnings history
Organon & Co. reported revenue of $6.22B for fiscal 2025 (year ended Dec 31, 2025), −2.9% on the year before, and net income of $187M.
Over 6 years, from fiscal 2019 to fiscal 2025, revenue grew at a compound rate of −3.7% a year.
Revenue and net income, 7 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025ended Dec 31, 2025 | $6.22B−2.9% | — | $187M | $700M | $162M | $538M | $77M | — | $88M | $574M | $8.64B | 10-K |
| 2024ended Dec 31, 2024 |
The latest quarter, insider trades and fund moves: Organon & Co. (OGN) on OQRO.
Common questions
What was Organon & Co.'s revenue in fiscal 2025?
$6.22B for the year ended Dec 31, 2025, as reported in its 10-K filed Feb 24, 2026. That is −2.9% on fiscal 2024 ($6.4B).
How fast has Organon & Co.'s revenue grown?
From $7.78B in fiscal 2019 to $6.22B in fiscal 2025: a compound annual growth rate of −3.7% over 6 years. This is arithmetic on the filed figures and says nothing about the years ahead.
Has Organon & Co. been profitable?
Where these figures come from
The SEC’s companyfacts data: every figure Organon & Co. tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.
